No mortality benefit seen with methyiprednisolone in ARDS

Snelson, C.
July 2006
Thorax;Jul2006, Vol. 61 Issue 7, p639
Academic Journal
The article reports that the use of methylprednisolone in acute respiratory distress syndrome(ARDS) does not confer any survival benefit and may be harmful if initiated late. The information was unveiled through a trial involving 180 intubated and mechanically ventilated patients 7-28 days after the onset of ARDS and were given methylprednisolone or placebo.


Related Articles

  • Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. Cohen, Alexander T.; Davidson, Bruce L.; Gallus, Alexander S.; Lassen, Michael R.; Prins, Martin H.; Tomkowski, Witold; Turpie, Alexander G. G.; Egberts, Jan F. M.; Lensing, Anthonie W. A. // BMJ: British Medical Journal (International Edition);2/11/2006, Vol. 332 Issue 7537, p325 

    Objective To determine the efficacy and safety of the anticoagulant fondaparinux in older acute medical inpatients at moderate to high risk of venous thromboembolism. Design Double blind randomised placebo controlled trial. Setting 35 centres in eight countries. Participants 849 medical patients...

  • Dry lung syndrome: complete airway collapse mimicking pulmonary hypoplasia? Losa, M.; Kind, C. // European Journal of Pediatrics;1998, Vol. 157 Issue 11, p935 

    Abstract. We observed a premature baby born after severe oligohydramnios who could not be ventilated efficiently even with very high pressures immediately after birth, but who, after cessation of resuscitation attempts, recovered spontaneous sufficient breathing during the following hour. After...

  • Pressures,Volumes, Outcomes, and Physiology in Mechanical Ventilation. Hess, Dean R. // Critical Care Alert;Nov2007, Vol. 15 Issue 8, p59 

    The article discusses lowering the tidal volume (VT) in patients with acute lung injury (ALI) or the acute respiratory distress syndrome (ARDS).

  • Lung-protective Ventilation Saves Lives: Why Aren't We Using It? Pierson, David J. // Critical Care Alert;Jun2008, Vol. 16 Issue 3, p19 

    Synopsis: In this cohort of patients who met accepted criteria for the diagnosis of ALI-ARDS, chart review showed that the majority did not receive lung-protective ventilation, in some cases even when it had been ordered. Prominent among the reasons given for not using it was diagnostic...

  • Information from Your Family Doctor: Acute Respiratory Distress Syndrome.  // American Family Physician;2/15/2012, Vol. 85 Issue 4, p365 

    Information is presented about Acute Respiratory Distress Syndrome (ARDS), including what it is, causes, treatments, and long-term effects.

  • Predictors of mortality in acute lung injury during the era of lung protective ventilation. Seeley, E.; McAuley, D. F.; Eisner, M.; Miletin, M.; Matthay, M.A.; KaIIet, A. H.; Kallet, R H // Thorax;Nov2008, Vol. 63 Issue 11, p994 

    Background: Lung protective ventilation has been widely adopted for the management of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Consequently, ventilator associated lung injury and mortality have decreased. It is not known if this ventilation strategy...

  • Neurodevelopmental defects after steroid treatment of premature lung disease. Johnson, K. E. // Thorax;Jun2004, Vol. 59 Issue 6, p464 

    There has been much controversy in recent years regarding the early use of postnatal corticosteroids to treat preterm infants with respiratory distress syndrome (RDS). Short term respiratory benefits must be weighed against the potential for detrimental neurodevelopmental effects. This study...

  • Long term effects of antenatal betamethasone on lung function: 30 year follow up of a randomised controlled trial. Dalziel, S. R.; Rea, H. H.; Walker, N. K.; Parag, V.; Mantell, C.; Rodgers, A.; Harding, J. E. // Thorax;Aug2006, Vol. 61 Issue 8, p678 

    Background: Antenatal betamethasone is routinely used for the prevention of neonatal respiratory distress syndrome in preterm infants. However, little is known of the long term effects of exposure to antenatal betamethasone on lung function in adulthood. Methods: Five hundred and thirty four 30...

  • BTS/BLF Young Investigators Prize Symposium.  // Thorax;Dec2004 Supplement, Vol. 59, p1 

    This article presents abstracts of several medical studies. A study was conducted to test the hypothesis that a sustained infusion of intravenous salbutamol would reduce extravascular lung water in patients with acute respiratory distress syndrome (ARDS). ARDS is characterised by increased...


Read the Article


Sign out of this library

Other Topics